
SPAC
Talawar Tx SPAC Merger: A $120M Biotech Bet with Cash Clock
Talawar Tx is a preclinical biotechnology company developing bispecific antibodies for immunology and inflammatory diseases, and it is going public through a merger with JATT II Acquisition Corp. The deal points to a second-half-2026 close, with a big PIPE supporting the transaction, but shareholders should watch redemption risk and whether the cash stack still clears the minimum funding bar.
Jul 5, 20266 MIN